Mental Health Daily

Caffeine to Prevent Alzheimer’s Disease via Adenosine A2A Receptors? (2023 Review)

by GLOOM

Alzheimer’s Disease (AD), a prevalent form of dementia, poses significant challenges for individuals and healthcare systems worldwide. Current treatments primarily offer symptomatic relief without altering the disease’s progression. However, emerging research suggests that caffeine, a widely consumed psychoactive substance, may have neuroprotective properties against AD. Highlights: Alzheimer’s Disease is the most common form of dementia, …

Aesthetic Chills to Treat Depression? Psychogenic Shivers, Frisson, Goosebumps (2024 Study)

by GLOOM

Depression, a prevalent mental health issue, often resists traditional treatments, making innovative approaches necessary. Recent research suggests that ‘aesthetic chills’—a peak emotional response accompanied by physical sensations like goosebumps—might offer significant benefits in treating depression. Highlights: Prevalence of Depression: Over 300 million people worldwide suffer from depression, making it a critical global health concern. Limitations …

Comparison of Brexipiprazole vs. Aripiprazole for Treatment-Resistant Depression (2024 Study)

by GLOOM

Antidepressant-resistant major depressive disorder (AR-MDD) poses significant challenges in psychiatric treatment. Antipsychotics like aripiprazole (ARI) and brexpiprazole (BRE) have emerged as effective adjunct therapies that may be more tolerable than older antipsychotics. Highlights: Both Brexipiprazole and Aripiprazole demonstrated better efficacy than placebo in treating AR-MDD in Japanese patients. Brexipiprazole showed a higher discontinuation rate due …

KNT-127 for Anxiety: Delta Opioid Receptor Agonist via PL-BLA Pathway (2023 Study)

by GLOOM

Recent scientific advancements have illuminated the crucial role of the prelimbic cortex to basolateral amygdala (PL-BLA) pathway in regulating anxiety-like behaviors. Utilizing cutting-edge optogenetic techniques and selective delta-opioid receptor (DOP) agonists, researchers have begun to decode the complex neural circuitry underlying anxiety disorders. Highlights: PL-BLA Pathway Significance: The connection between the prelimbic cortex (PL) and …

Analyzing Brain Connectivity with Advanced Neuroimaging to Treat Major Depression (2023 Research)

by GLOOM

Depression, a leading cause of disability globally, presents a myriad of treatment challenges. Recent advancements in neuroimaging, particularly in understanding brain connectivity, offer a new lens through which we can view and potentially enhance the treatment of Major Depressive Disorder (MDD). Highlights: Major Depressive Disorder (MDD) affects millions worldwide, with traditional treatments showing varied success …

Vitamin D for Prevention & Treatment of Parkinson’s Disease? (2023 Research)

by GLOOM

Parkinson’s disease (PD), a prevalent neurodegenerative brain disease, is marked by the loss of dopaminergic neurons in the substantia nigra. Recent research has illuminated the significant role of Vitamin D (VD) in the brain, particularly its neuroprotective effects on these neurons. Highlights: Vitamin D’s Role in the Brain: Beyond its well-known functions in bone health, …

Morus Alba (White Mulberry): Medical Uses, Health Effects, Mechanisms (2023 Research)

by GLOOM

Morus alba, a member of the Moraceae family, is not only known for its role in sericulture but also for its therapeutic potential. The plant’s traditional uses are backed by scientific research, indicating its effectiveness in various medical conditions. Highlights: Morus alba is utilized in traditional medicine for its analgesic, antibacterial, antidiabetic, and anti-inflammatory properties. …